Bio-Rad launches SARS-CoV-2 S gene variant controls

Create PDF

Aug. 13, 2021—Bio-Rad Laboratories has launched SARS-CoV-2 S gene alpha, beta, gamma, and epsilon variant controls.

The Exact Diagnostics SARS-CoV-2 S gene variant controls are intended to be validated as independent external run controls and are for research testing with molecular assays targeting mutations in the spike gene. The products are for use with assays that detect SARS-CoV-2 variant RNA and are processed in the same manner as patient specimens.